REGISTER TO WATCH ON DEMAND

 

Overview

Kidney disease is a leading driver of health care costs and poor outcomes for members of health insurance plans. New value-based approaches to kidney disease are helping members slow progression of disease and avoid or delay dialysis treatment, lowering the total cost of care, and improving quality of life for members.

Identifying health plan members most at-risk of kidney disease progression through predictive analytics combined with a comprehensive approach to care management and support is showing exciting results. Leading nephrologists will explain how their shift to value-based care is helping better manage comorbid conditions including diabetes, hypertension, and depression, which drive progression of kidney disease.

 

Attendees Will Learn About

• The role of value-based care in slowing CKD progression and lowering costs to payers
• How machine learning can predict progression and assist with delivering the right care at the right time
• How nephrologists are shifting to value-based care models to better manage comorbid conditions

 

Presenters

George Hart, MD
Chief Medical Officer
Interwell Health 

David Pollack
President and Chief Operating Officer
Interwell Health

Kezia Alberto, MD
Nephrologist
Nephrological Associates in New Jersey

Nauman Shahid, MD
Nephrologist
Eastern Nephrology Associates in North Carolina